Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sun Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Sun Pharmaceuticals Industries Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

02 Nov 2016 Wright Reports 68 $75.00

Thomson Reuters Stock Report - Sun Pharmaceutical Industries Ltd (SUNPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 11 $25.00

Company Snapshot - Sun Pharmaceuticals Industries

A director at Sun Pharmaceuticals Industries sold 1,944,805 shares at 0.000INR and the significance rating of the trade was 6...

17 Oct 2016 Directors Deals Ltd. 1 $12.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

05 Oct 2016 GlobalData 175 $300.00

MOSL: ANNUAL REPORT THREADBARE (ART) | SUN PHARMACEUTICAL FY16-Tax rates remain low, contingent liability on a rise

ANNUAL REPORT THREADBARE (ART) | SUN PHARMACEUTICAL FY16: Tax rates remain low, contingent liability on a rise Sun Pharma’...

28 Sep 2016 Motilal Oswal Securities Ltd. 14 $138.00

Spark Capital: Sun Pharmaceutical Industries – Company update – Rating: REDUCE; TP: 796

Sun Pharmaceutical Industries – Pricing concerns at Taro; downgrade to REDUCE Taro’s rising contribution to SUNP’s profi...

22 Sep 2016 Spark Capital Advisors(India) Private Limited 10 $92.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

20 Sep 2016 GlobalData 175 $300.00

MOSL: SUN PHARMA 1QFY17 (Buy)-Strong quarter led by gGleevec-Base business ramp-up is key

SUN PHARMA 1QFY17: Strong quarter led by gGleevec; Base business ramp-up is key (SUNP IN, Mkt Cap USD28.9b, CMP INR802, TP I...

16 Aug 2016 Motilal Oswal Securities Ltd. 12 $115.00

Spark Capital: 1QFY17 outlook review of Sun Pharmaceutical Industries (Rating: ADD, TP: Rs. 817)

1QFY17 outlook review of Sun Pharmaceutical Industries (Rating: ADD, TP: Rs. 817) How does our one year outlook change? ...

16 Aug 2016 Spark Capital Advisors(India) Private Limited 6 $46.00